SCHEMBL5481733

SCHEMBL5481733

Nc1ccc(C2(c3ccc(N)cc3)C(=O)Nc3sccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
OPRK1 P41145 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP19A1 P11511 12/20 0.36
CHRM2 P08172 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
KCNH2 Q12809 1/20 0.35
CNR1 P21554 1/20 0.35
HTT P42858 1/20 0.35
GPR35 Q9HC97 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
TBXAS1 P24557 2/20 0.33
CYP3A4 P08684 2/20 0.32
CYP17A1 P05093 1/20 0.32
CYP11A1 P05108 1/20 0.32
PMP22 Q01453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9342160 0.69 LMNA (0.73) LMNAKDM4EMEN1MAPTOPRK1
SCHEMBL5481736 0.63 CYP19A1 (0.36) LMNAKDM4EMEN1MAPTOPRK1
SCHEMBL5478213 0.63 CNR1 (0.40) LMNAKDM4EMEN1MAPTOPRK1
SCHEMBL5483177 0.63 LMNA (0.37) LMNAKDM4EMEN1MAPTOPRK1
SCHEMBL17813127 0.62 LMNA (0.59) LMNAKDM4EMEN1MAPTOPRK1
SCHEMBL5483481 0.61 CHRM2 (0.62) LMNAMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL21637651 0.59 MAPT (0.71) LMNAKDM4EMEN1MAPTOPRK1
Sulfur Dioxide SCHEMBL29071683 0.58 MEN1 (0.67) LMNAKDM4EMEN1MAPTKMT2A
Sulfur Dioxide SCHEMBL27275368 0.58 MEN1 (0.67) LMNAKDM4EMEN1MAPTKMT2A
SCHEMBL4387188 0.57 MEN1 (0.78) LMNAKDM4EMEN1MAPTOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299102-A1 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer TOPO TARGET A/S (DK) 2007-12-27 US disclosed
EP-1734951-A2 DIPHENYL-INDOL-2-ON COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER TopoTarget A/S (DK) 2006-12-27 EP disclosed
WO-2005097107-A2 DIPHENYL - INDOL-2-ON COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER TOPOTARGET A/S (DK) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299102-A1 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer MTOR, RICTOR, CDK4 LMNA 3104/4885KDM4E 420/4885MEN1 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.